Experimental Physiology
	

Celebrating 100 years
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiology in Press

First published online on March 14, 2008.
Experimental Physiology (2008)
DOI: 10.1113/expphysiol.2008.042176
© The Physiological Society 2008

A more recent version of this article appeared on July 1, 2008
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
93/7/834    most recent
expphysiol.2008.042176v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rabkin, S. W
Right arrow Articles by Tsang, M. Y
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rabkin, S. W
Right arrow Articles by Tsang, M. Y

Received January 23, 2008
Revised February 14, 2008
Accepted after revision February 14, 2008


Heart/Cardiac Muscle [240]

The action of nitric oxide to enhance cell survival is mediated through a cGMP and ERK 1,2 pathway while p38 mitogen activated protein kinase dependent pathways do not alter cell death

Simon W Rabkin 1* Michael Y Tsang 1

1 University of British Columbia

* To whom correspondence should be addressed. E-mail: rabkin{at}interchange.ubc.ca.


   Abstract
The objective of this study was to determine whether the dual action of nitric oxide (NO) on cardiomyocyte cell viability is mediated through p38 mitogen activated protein kinase (MAPK)-induced cell death and ERK 1,2 mediated cell survival pathways; and whether either of these is mediated through a cGMP/protein kinase G (PKG) pathway. Cell viability of cardiomyocytes from embryonic chick cardiomyocytes was assessed by the MTT assay, which is based on the ability of viable cells to reduce MTT. The NO donor sodium nitroprusside (SNP) produced a significant (p<0.01) concentration dependent reduction in cell viability or increase in cell death. SNP induced ERK1,2 phosphorylation and the MEK1,2 inhibitor PD 98059 significantly increased cell death. In contrast, SB202190, a relatively selective inhibitor of p38 MAPK, did not affect SNP-induced cell death. The cardioprotective effect of NO was likely mediated, in part through cGMP as ODQ a selective inhibitor of NO-sensitive guanylyl cyclase produced a significant enhancement of SNP-induced cell death. In contrast, the PKG inhibitor KT 5823 did not affect cell viability. In summary, these data suggest that NO through stimulation of soluble guanylyl cyclase activates MEK1,2 whose products ERK1,2 protects against cell death. In contrast, SNP-induced p38 MAPK activation does not modulate NO-induced cardiomyocyte cell death. Not all cGMP targets affect NO-induced cell death as the PKG pathway does not enhance or suppress NO-induced cardiomyocyte cell death. Enhancement of the ERK1,2 responses to NO may permit the beneficial effects of NO to predominate.

Key Words: Cell signalling, Heart, Nitric oxide







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the The Physiological Society.